Results 291 to 300 of about 356,853 (386)

Valid concerns: Considerations for reviewing manuscripts with validity arguments

open access: yes
Anatomical Sciences Education, EarlyView.
Georgina C. Stephens, Mahbub Sarkar
wiley   +1 more source

Expert insight into the education of healthcare professionals on medication adherence

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Medication non‐adherence is a global health problem affecting patients with numerous medical conditions. Training healthcare professionals (HCPs) on managing the challenging issue of medication non‐adherence requires an evidence‐based approach.
Fatima Rezae   +3 more
wiley   +1 more source

The potential for clinical pharmacists to support older people with dementia in the community: A qualitative interview study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims The prevalence of multiple long‐term health conditions including dementia is rising globally. Managing dementia presents significant challenges for healthcare providers. Clinical pharmacists, with expertise in medication management, have emerged as valuable members of the primary care team.
Alice Burnand   +13 more
wiley   +1 more source

78.開心手術症例の急性期ST上昇の臨床的意義 コイル加熱型連続心拍出測定装置(Vigilance)を用いて : 第71回日本医科器械学会大会予稿集

open access: gold, 1996
久保田 浩光   +8 more
openalex   +2 more sources

Completeness of spontaneously reported adverse drug reactions in 4 databases

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims To assess the completeness of information provided in adverse drug reaction (ADR) reports in 4 spontaneous report databases. Methods The study was conducted using freely accessible ADR reports from the Canada Vigilance Adverse Reaction Online Database, the US Food and Drug Administration Adverse Event Reporting System (FAERS) database, the UK ...
Mohammed Gebre Dedefo   +5 more
wiley   +1 more source

Testicular tumor in an infant: A case report. [PDF]

open access: yesUrol Case Rep
Tello BC   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy